WealthTrust-Arizona’s Regeneron Pharmaceuticals REGN Stock Holding History

WealthTrust-Arizona’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-9	Closed	-$4K	–	714
2018 Q3	$4K	Hold	9	–	–	﹤0.01%	533
2018 Q2	$3K	Hold	9	–	–	﹤0.01%	557
2018 Q1	$3K	Hold	9	–	–	﹤0.01%	545
2017 Q4	$3K	Hold	9	–	–	﹤0.01%	558
2017 Q3	$4K	Hold	9	–	–	﹤0.01%	528
2017 Q2	$4K	Buy	+9	New	+$3.94K	﹤0.01%	511
2016 Q4	–	Sell	-9	Closed	-$4K	–	637
2016 Q3	$4K	Hold	9	–	–	﹤0.01%	502
2016 Q2	$3K	Hold	9	–	–	﹤0.01%	519
2016 Q1	$3K	Sell	9 -12	-57%	-$4.95K	﹤0.01%	514
2015 Q4	$11K	Sell	21 -4	-16%	-$2.17K	0.01%	367
2015 Q3	$12K	Sell	25 -1	-4%	-$537	0.01%	351
2015 Q2	$13K	Hold	26	–	–	0.01%	359
2015 Q1	$12K	Hold	26	–	–	0.01%	382
2014 Q4	$11K	Sell	26 -100	-79%	-$39.3K	0.01%	386
2014 Q3	$45K	Buy	126 +8	+7%	+$2.68K	0.05%	168
2014 Q2	$33K	Sell	118 -4	-3%	-$1.19K	0.04%	217
2014 Q1	$37K	Hold	122	–	–	0.04%	199
2013 Q4	$34K	Hold	122	–	–	0.04%	195
2013 Q3	$38K	Buy	+122	New	+$32.1K	0.05%	159

Other funds holding REGN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

WealthTrust-Arizona's REGN Position: Q4 2018 in Review

WealthTrust-Arizona sold out of Regeneron Pharmaceuticals (REGN) in Q4 2018, closing a stake of 9 shares — an estimated $4K sold.

WealthTrust-Arizona first reported a position in REGN in Q3 2013 and held it in 19 quarters. The position peaked at $45K in Q3 2014. 670 funds tracked by Wall St. Rank hold REGN as of Q4 2018.

WealthTrust-Arizona reported no remaining Regeneron Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
WealthTrust-Arizona sold 9 Regeneron Pharmaceuticals shares in Q4 2018, an estimated $4K.
WealthTrust-Arizona first reported a position in Regeneron Pharmaceuticals in Q3 2013 and held it in 19 quarters.
WealthTrust-Arizona's Regeneron Pharmaceuticals position peaked at $45K in Q3 2014.
670 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2018.

Based on WealthTrust-Arizona's 13F filing for Q4 2018, filed 7 Feb 2019.